Top

Breast Cancer Research and Treatment

Published in:

01-02-2021 | Breast Cancer | Letter to the Editor

Letter to editor re: Shah et al.: “The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements”

Authors: Cheryl L. Brunelle, Andrea V. Barrio, Alphonse G. Taghian

Published in: Breast Cancer Research and Treatment | Issue 1/2021

Excerpt

To the editor, …

Laidley A, Anglin B (2016) The impact of L-Dex measurements in assessing breast cancer-related lymphedema as part of routine clinical practice. Front Oncol 7:2–7. https://doi.org/10.3389/fonc.2016.00192CrossRef

Barrio AV, Eaton A, Frazier TG (2015) A prospective validation study of bioimpedance with volume displacement in early-stage breast cancer patients at risk for lymphedema. Ann Surg Oncol 22:370–375. https://doi.org/10.1245/s10434-015-4683-0CrossRefPubMedCentral

Ancukiewicz M, Miller CL, Skolny MN, O’Toole J, Warren LE, Jammallo LS et al (2012) Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology. Breast Cancer Res Treat 135:145–152. https://doi.org/10.1007/s10549-012-2111-8CrossRefPubMedPubMedCentral

Title: Letter to editor re: Shah et al.: “The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements”
Authors: Cheryl L. Brunelle
Andrea V. Barrio
Alphonse G. Taghian
Publication date: 01-02-2021
Publisher: Springer US
Keywords: Breast Cancer
Lymphedema
Breast Cancer
Published in: Breast Cancer Research and Treatment / Issue 1/2021
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-021-06139-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?

Spindle and kinetochore‑associated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/β-catenin signaling

Germline BRCA-mutated metastatic breast cancer with positive hormone receptor

HER2 fluorescent in situ hybridization signal degradation: a 10-year retrospective study

Potential of using mammography screening appointments to identify high-risk women: cross sectional survey results from the national health interview survey

Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?

Keynote webinar | Spotlight on antibody–drug conjugates in cancer